IL10 and neoplasm: Several candidate biomarkers—most notably interleukin-10 (IL-10), the IL-10/IL-6 ratio, CXCL13, and free light chains—demonstrate diagnostic potential, while more recent mass spectrometry studies have identified additional proteins such as LCP1, SGCE, and AGRN that correlate with treatment response and tumour burden [20].